This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Nature Structural & Molecular Biology | |
|---|---|
| Title | Nature Structural & Molecular Biology |
| Cover | Nature_Structural_%26_Molecular_Biology_cover.jpg |
| Discipline | Structural biology; Molecular biology; Biophysics |
| Abbreviation | Nat. Struct. Mol. Biol. |
| Publisher | Nature Research |
| Country | United Kingdom |
| Frequency | Monthly |
| History | 1994–present |
| Impact | 17.0 |
| Impact-year | 2024 |
| Issn | 1545-9993 |
Nature Structural & Molecular Biology is a monthly peer-reviewed scientific journal focusing on structural biology, molecular biology, and related fields. Launched in the mid-1990s, the journal publishes original research, reviews, and perspectives that intersect techniques such as X-ray crystallography, cryo-electron microscopy, nuclear magnetic resonance, and single-molecule methods. It sits within the portfolio of Nature Research and is widely cited by researchers affiliated with institutions such as Harvard University, Stanford University, Max Planck Society, and University of Cambridge.
The journal was founded in 1994 during a period of rapid expansion in structural methods alongside breakthroughs associated with groups at Cold Spring Harbor Laboratory, European Molecular Biology Laboratory, Massachusetts Institute of Technology, and MRC Laboratory of Molecular Biology. Early editors worked with contributors including investigators from Rockefeller University, University of Oxford, ETH Zurich, and companies such as Genentech and GlaxoSmithKline to shape editorial priorities. Its development paralleled landmark achievements recognized by awards like the Nobel Prize in Chemistry and the Lasker Award, and it has chronicled advances linked to figures associated with Howard Hughes Medical Institute and major consortia such as the Human Genome Project.
The scope covers macromolecular structure, dynamics, assembly, and mechanisms reported by laboratories at California Institute of Technology, Yale University, University of California, Berkeley, and Johns Hopkins University. Articles connect methods from laboratories at EMBL-EBI, Riken, Scripps Research, and Weizmann Institute of Science with biological systems studied in contexts such as work by teams at Salk Institute, University of Tokyo, Peking University, and Karolinska Institutet. Typical content includes structural studies tied to pathways involving proteins first described by groups at NIH, Wellcome Trust, or biopharmaceutical firms like Pfizer and Novartis. Reviews and perspectives often cite historical milestones involving Rosalind Franklin-era findings, conceptual frameworks linked to Francis Crick, and method developments propelled by researchers from Bell Labs and IBM Research.
The editorial board has included scientists with appointments at University of California, San Francisco, Columbia University, University of Chicago, Imperial College London, and Duke University. Manuscript submission, peer review, and production are managed by staff within Springer Nature divisions collaborating with editorial offices in London and regional offices near New York City and Singapore. The journal issues monthly volumes and runs special features alongside regular sections that highlight advances from labs at Broad Institute, Institute Pasteur, Chinese Academy of Sciences, and Australian National University.
The journal is indexed in major services including Science Citation Index, MEDLINE, PubMed, Scopus, and EMBASE, facilitating discoverability by researchers affiliated with University of Edinburgh, McGill University, Seoul National University, and University of Sydney. Its metadata are tracked by organizations such as CrossRef, Clarivate Analytics, and Altmetric providers used by institutions like National Institutes of Health and European Research Council.
The journal has been influential in reporting structural determinations that inform drug discovery pipelines at companies like AstraZeneca, Bayer, and Amgen. Citation metrics and commentary from editorialists at Nature Medicine, Cell, Science, and PNAS reflect its role in advancing cryo-EM revolutions credited to teams at University of California, San Diego and Yale School of Medicine. Its published work has shaped fields recognized by prizes such as the Wolf Prize and has been discussed in symposia at Gordon Research Conferences and meetings organized by Cold Spring Harbor Laboratory.
Notable contributions include high-resolution structures and mechanistic studies from researchers associated with RCSB Protein Data Bank, European Synchrotron Radiation Facility, Diamond Light Source, and National Synchrotron Light Source II. Landmark reports have originated from collaborative groups at University of Basel, University of Copenhagen, University of Toronto, and Vanderbilt University, and have influenced therapeutic strategies pursued by Roche and academic centers such as Dana-Farber Cancer Institute. The journal has published work connected to structural elucidation of complexes studied by investigators at University of Illinois Urbana-Champaign, Northwestern University, University of Copenhagen, and John Innes Centre.
Published under the policies of Nature Research and Springer Nature, the journal offers a mix of subscription-based content and open-access options compliant with mandates from funders such as Wellcome Trust, UK Research and Innovation, and the European Commission. Authors affiliated with agencies like National Science Foundation and European Research Council may choose gold open access or pay hybrid fees, with licensing handled through agreements aligning with standards from Creative Commons and institutional deals negotiated with consortia including Jisc and Elsevier (licensing counterpart discussions).
Category:Biology journals Category:English-language journals